cefotaxime and Lung-Diseases--Obstructive

cefotaxime has been researched along with Lung-Diseases--Obstructive* in 3 studies

Trials

1 trial(s) available for cefotaxime and Lung-Diseases--Obstructive

ArticleYear
[Effectiveness of comprehensive therapy of broncho-obstructive syndrome].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1994, Volume: 39, Issue:5

    Patients with chronic obstructive diseases of the lungs and bronchial asthma were treated with terbutaline sulfate in combination with cefotaxime. The results of the treatment were found to be favourable.

    Topics: Asthma; Cefotaxime; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Lung Diseases, Obstructive; Middle Aged; Syndrome; Terbutaline

1994

Other Studies

2 other study(ies) available for cefotaxime and Lung-Diseases--Obstructive

ArticleYear
[Distribution and drug-resistance of 345 strains gram-negative bacilli from hospitalized patients with lower respiratory tract infections diseases].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1998, Volume: 21, Issue:10

    To investigate the distribution and drug-resistance of gram-negative bacilli in respiratory ward.. (1) Drug-resistance was tested by Kirby-Bauer disk sensitivity method and MIC by agar doubling dilution. (2) beta-lactanase was tested by nitrocephin. (3) ESBLs was tested by E test.. (1) Among 345 strains gram-negative bacillus, klebsiella pneumoniae and pseudomonas aeruginoea was about 39.7%, 17.4%, respectively. (2) Drug-resistance rate of cefotaxime dropped from 42.9% (6 years ago) to 8.2%. (3) beta-lactamase positive rate of 345 strains bacilli was 54.5%. (4) ESBLs was negative.. (1) Klebsiella pneumoniae and pseudomonas aerugries were the main pathogens in lower respiratory tract infection in hospital. (2) Although we didn't find the evidence of ESBLs, we should pay more attention to it in the future.

    Topics: Bronchiectasis; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Lung Diseases, Obstructive; Pseudomonas aeruginosa; Respiratory Tract Infections

1998
Once-a-day cefixime versus co-amoxiclav three times daily in the treatment of lower respiratory infections.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 35, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Respiratory Tract Infections; Sputum

1995